Clinical trial
An Open, Randomized, Multicentre, Phase II Pilot Study
NCT00293085 · Central European Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00293085 |
|---|---|
| Title | An Open, Randomized, Multicentre, Phase II Pilot Study |
| Official title | An Open, Randomized, Multicentre, Phase II Pilot Study of Docetaxel and Cisplatin in the Adjuvant Treatment of Non-Small Cell Lung Cancer (NSCLC) Stage I-II |
| Lead sponsor | Central European Cooperative Oncology Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel |
| Enrollment | 37 |
| Start date | Dec 1, 2001 |
| Completion | Sep 1, 2003 |
| First posted | Feb 17, 2006 |
| Last update posted | Jun 23, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: